The Massengill Company marketed Elixir Sulfanilamide in 1937 using diethylene glycol, a chemical analogue of antifreeze, as a solvent for the recently discovered systemic treatment for infections. The toxic product resulted in the deaths of more than 100, including many children, and led to mandatory pre-market FDA clearance of drugs.